Isoprenaline Hydrochloride Macure Healthcare

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Hydrochloride Macure Healthcare, is a non‑selective beta‑adrenergic agonist presented as a sterile solution for intravenous use. It is employed to raise heart rate in bradycardia, improve conduction in heart block, and relax airway smooth muscle in asthma and bronchospasm. GNH USA supplies Isoprenaline Hydrochloride Macure Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Isoprenaline Hydrochloride acts on the cardiac and respiratory adrenergic pathways to restore normal rhythm and airway tone. - Bradycardia: increases heart rate to alleviate symptomatic slow rhythm. - Heart block: enhances atrioventricular conduction to improve cardiac output. - Asthma: relaxes bronchial smooth muscle to relieve airway obstruction. - Bronchospasm: induces bronchodilation for acute respiratory distress.

Isoprenaline Hydrochloride may cause a range of adverse reactions during intravenous administration.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Palpitations: sensation of irregular or forceful heartbeats. - Headache: mild to moderate cranial discomfort. - Tremor: fine muscle shaking, especially in the hands. - Nausea: feeling of stomach upset. - Anxiety: heightened nervousness or restlessness.

Serious or Rare Side Effects: - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Myocardial ischemia: reduced blood flow to heart muscle. - Severe hypotension: dangerous drop in blood pressure. - Paradoxical bronchospasm: unexpected airway constriction. - Anaphylactic reaction: severe allergic response. - Cardiac arrest: sudden loss of heart function.

When using Isoprenaline Hydrochloride, clinicians should observe several safety measures. - Cardiac monitoring: continuously assess heart rate and rhythm during infusion. - Dose titration: adjust infusion rate gradually to avoid excessive tachycardia. - Contraindications: avoid in patients with severe tachyarrhythmias or recent myocardial infarction. - Pregnancy: prescribe only if potential benefit justifies potential risk to the fetus. - Drug interactions: review concomitant beta‑blocker therapy before administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Isoprenaline Hydrochloride can interact with several cardiovascular and respiratory agents.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may antagonize therapeutic effect. - Class IA antiarrhythmics (e.g., quinidine): increase risk of severe arrhythmias. - Monoamine oxidase inhibitors: potential for hypertensive crisis.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: additive cardiac effects requiring monitoring. - Diuretics: may exacerbate electrolyte disturbances. - Theophylline: heightened risk of tachycardia and arrhythmia.